These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 12678273)

  • 1. Visual evoked potentials in patients with Graves' ophthalmopathy complicated by ocular hypertension and suspect glaucoma or dysthyroid optic neuropathy.
    Ambrosio G; Ferrara G; Vitale R; De Marco R
    Doc Ophthalmol; 2003 Mar; 106(2):99-104. PubMed ID: 12678273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring contrast sensitivity in patients with Graves' ophthalmopathy complicated by ocular hypertension and suspect glaucoma or dysthyroid optic neuropathy.
    De Marco R; Ambrosio G; Ferrara G
    Doc Ophthalmol; 2000 Sep; 101(2):165-77. PubMed ID: 11200548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical ability of pattern electroretinograms and visual evoked potentials in detecting visual dysfunction in ocular hypertension and glaucoma.
    Parisi V; Miglior S; Manni G; Centofanti M; Bucci MG
    Ophthalmology; 2006 Feb; 113(2):216-28. PubMed ID: 16406535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pattern visual evoked potentials in the early diagnosis of optic neuropathy in the course of Graves' ophthalmopathy.
    Pawłowski P; Myśliwiec J; Mrugacz M; Bakunowicz-Łazarczyk A; Górska M
    Endokrynol Pol; 2006; 57(2):122-6. PubMed ID: 16773586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular Hypertension, Glaucoma or Compressive Neuropathy in Patient with Active TED.
    Stoyanova NS; Konareva-Kostianeva MI; Mitkova-Hristova VT
    Folia Med (Plovdiv); 2020 Jun; 62(2):418-423. PubMed ID: 32666771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychophysical and electrophysiological testing in ocular hypertension.
    Nebbioso M; Gregorio FD; Prencipe L; Pecorella I
    Optom Vis Sci; 2011 Aug; 88(8):E928-39. PubMed ID: 21532514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Visual evoked potentials in diagnosis and monitoring of optic neuropathy in the course of thyroid ophthalmopathy].
    Rutecka-Debniak A; Lubiński W; Krzystolik Z
    Klin Oczna; 1999; 101(5):361-5. PubMed ID: 10714075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Course of pattern-reversed visual evoked cortical potentials in 30 eyes after bony orbital decompression in dysthyroid optic neuropathy.
    Lipski A; Eckstein A; Esser J; Loesch C; Mann K; Mohr C; Jurklies B
    Br J Ophthalmol; 2011 Feb; 95(2):222-6. PubMed ID: 20584712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of visual evoked potentials in dysthyroid optic neuropathy.
    Garip Kübler A; Halfter K; Reznicek L; Klingenstein A; Priglinger S; Rudolph G; Hintschich C
    Orbit; 2023 Oct; 42(5):475-480. PubMed ID: 36128945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual function changes of dysthyroid optic neuropathy and ROC curve analysis for early diagnostic indicators.
    Wang S; Wang J; Chen L; Tan J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 48(8):1197-1202. PubMed ID: 37875359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flash and pattern visual evoked potentials in the diagnosis and monitoring of dysthyroid optic neuropathy.
    Tsaloumas MD; Good PA; Burdon MA; Misson GP
    Eye (Lond); 1994; 8 ( Pt 6)():638-45. PubMed ID: 7867819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of multifocal visual evoked potentials in patients with Graves' orbitopathy and subclinical optic nerve involvement.
    Pérez-Rico C; Rodríguez-González N; Arévalo-Serrano J; Blanco R
    Doc Ophthalmol; 2012 Aug; 125(1):11-9. PubMed ID: 22581376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ocular hypertension and optic neuropathies secondary to dysthyroid orbitopathy: Review of the literature].
    Bellot L; Graber M; Laurent C; Mouriaux F
    J Fr Ophtalmol; 2021 Oct; 44(8):1256-1261. PubMed ID: 34303550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early detection of P-VEP and PERG changes in ophthalmic Graves' disease.
    Spadea L; Bianco G; Dragani T; Balestrazzi E
    Graefes Arch Clin Exp Ophthalmol; 1997 Aug; 235(8):501-5. PubMed ID: 9285219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromatic visual evoked potentials identify optic nerve dysfunction in patients with Graves' orbitopathy.
    Yu Y; Shi B; Cheng S; Liu Y; Zhu R; You Y; Chen J; Pi X; Wang X; Jiang F
    Int Ophthalmol; 2022 Dec; 42(12):3713-3724. PubMed ID: 35635597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of visual evoked potentials in optic neuropathy of Graves' disease.
    Setälä K; Raitta C; Välimäki M; Katevuo V; Lamberg BA
    J Endocrinol Invest; 1992 Dec; 15(11):821-6. PubMed ID: 1291594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast sensitivity function in Graves' ophthalmopathy and dysthyroid optic neuropathy.
    Suttorp-Schulten MS; Tijssen R; Mourits MP; Apkarian P
    Br J Ophthalmol; 1993 Nov; 77(11):709-12. PubMed ID: 8280684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripapillary and Macular Vessel Density in Dysthyroid Optic Neuropathy: An Optical Coherence Tomography Angiography Study.
    Zhang T; Xiao W; Ye H; Chen R; Mao Y; Yang H
    Invest Ophthalmol Vis Sci; 2019 May; 60(6):1863-1869. PubMed ID: 31042792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The visual evoked potential in glaucoma and ocular hypertension: effects of check size, field size, and stimulation rate.
    Towle VL; Moskowitz A; Sokol S; Schwartz B
    Invest Ophthalmol Vis Sci; 1983 Feb; 24(2):175-83. PubMed ID: 6826322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early diagnosis of Graves' optic neuropathy using visual evoked responses.
    Batch JA; Lepre F
    Postgrad Med J; 1990 Aug; 66(778):664-6. PubMed ID: 2217037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.